Abbott to acquire Alere for $5.8 billion

Abbott said that it has signed a definitive deal to acquire Alere for a net value of $5.8 billion in cash. Abbott expects the acquisition to be immediately accretive to its earnings per share upon completion.

Read Full Article

France, Germany suspend some drug approvals over Indian data

Regulators in France, Germany, Belgium and Luxembourg are suspending the marketing approval of 25 generic drugs due to concerns over the quality of data from clinical trials conducted by India's GVK Biosciences, French watchdog ANSM said on Friday.

Read Full Article

UK-based Dentsu Aegis acquires Chinese social creative firm Verawom

Media and digital marketing firm Dentsu Aegis Network added China-based social creative firm Verawom for an undisclosed sum, in a deal that will integrate the latter into the Isobar China group.

Read Full Article

Abbot closes deal in acquisition of IDEV Technologies

Abbott announced the completion of its purchase of IDEV Technologies Wednesday.

Read Full Article

Abbot acquires IDEV Technologies for USD 310 million

Abbott completed its purchase of IDEV Technologies Inc for USD 310 million.

Read Full Article

Pharma giant assumes ownership of medical stent-producer IDEV

Abbott Laboratories is set to acquire all of IDEV Technologies' outstanding equity shares for US $30 million.

Read Full Article

Abbott to buy Idev Technologies and OptiMedica Corp. for US$560 million

Abbott Laboratories would purchase Idev Technologies and OptiMedica Corp. for around US$560 million as it expands its device offerings.

Read Full Article

Abbott to Acquire Action Pharma's Investigational Compound, AP214

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics